KVUE | Kenvue Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	23.56 - 23.78
52 Week Range	17.67 - 24.13
Beta	0.49
Implied Volatility	21.47%
IV Rank	2.89%
Day's Volume	5,484,910
Average Volume	15,477,119
Shares Outstanding	1,917,257,400
Market Cap	45,592,380,972
Sector	Consumer Defensive
Industry	Household & Personal Products
IPO Date	2023-05-04

Valuation
Profitability
Growth
Health
P/E Ratio	43.24
Forward P/E Ratio	N/A
EPS	0.55
1YR Price Target	N/A
Dividend Yield	3.46%
Dividend Per Share	0.82
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	22,000
Country	USA
Website	KVUE

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

KVUE's peers: COTY, ELF, HIMS, HNST, PG, UL

*Chart delayed

Analyzing fundamentals for KVUE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see KVUE Fundamentals page.

Watching at KVUE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on KVUE Technicals page.